• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导多能干细胞的制备和表观遗传记忆:组织来源重要吗?

iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?

机构信息

Department of Health Science, University of Milan, via A di Rudinì 8, 20142 Milan, Italy.

出版信息

Cells. 2021 Jun 11;10(6):1470. doi: 10.3390/cells10061470.

DOI:10.3390/cells10061470
PMID:34208270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8230744/
Abstract

The production of induced pluripotent stem cells (iPSCs) represent a breakthrough in regenerative medicine, providing new opportunities for understanding basic molecular mechanisms of human development and molecular aspects of degenerative diseases. In contrast to human embryonic stem cells (ESCs), iPSCs do not raise any ethical concerns regarding the onset of human personhood. Still, they present some technical issues related to immune rejection after transplantation and potential tumorigenicity, indicating that more steps forward must be completed to use iPSCs as a viable tool for in vivo tissue regeneration. On the other hand, cell source origin may be pivotal to iPSC generation since residual epigenetic memory could influence the iPSC phenotype and transplantation outcome. In this paper, we first review the impact of reprogramming methods and the choice of the tissue of origin on the epigenetic memory of the iPSCs or their differentiated cells. Next, we describe the importance of induction methods to determine the reprogramming efficiency and avoid integration in the host genome that could alter gene expression. Finally, we compare the significance of the tissue of origin and the inter-individual genetic variation modification that has been lightly evaluated so far, but which significantly impacts reprogramming.

摘要

诱导多能干细胞(iPSCs)的产生代表了再生医学的突破,为理解人类发育的基本分子机制和退行性疾病的分子方面提供了新的机会。与人类胚胎干细胞(ESCs)不同,iPSCs 不会引起任何关于人类人格开始的伦理问题。然而,它们在移植后的免疫排斥和潜在的致瘤性方面存在一些技术问题,这表明必须完成更多的步骤,才能将 iPSCs 用作体内组织再生的可行工具。另一方面,细胞来源可能对 iPSC 的产生至关重要,因为残留的表观遗传记忆可能会影响 iPSC 的表型和移植结果。在本文中,我们首先回顾了重编程方法和组织起源对 iPSCs 或其分化细胞的表观遗传记忆的影响。接下来,我们描述了诱导方法的重要性,以确定重编程效率并避免整合到宿主基因组中,这可能会改变基因表达。最后,我们比较了组织来源和个体间遗传变异修饰的重要性,到目前为止,后者虽然已经得到了一定程度的评估,但对重编程的影响却非常显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17b/8230744/b3fff6a48e36/cells-10-01470-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17b/8230744/af70a10bc195/cells-10-01470-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17b/8230744/ff19c8f9a61c/cells-10-01470-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17b/8230744/b3fff6a48e36/cells-10-01470-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17b/8230744/af70a10bc195/cells-10-01470-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17b/8230744/ff19c8f9a61c/cells-10-01470-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17b/8230744/b3fff6a48e36/cells-10-01470-g003.jpg

相似文献

1
iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?诱导多能干细胞的制备和表观遗传记忆:组织来源重要吗?
Cells. 2021 Jun 11;10(6):1470. doi: 10.3390/cells10061470.
2
The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.体细胞生成 iPS 细胞中的表观遗传重编程路线图。
J Genet Genomics. 2015 Dec 20;42(12):661-70. doi: 10.1016/j.jgg.2015.10.001. Epub 2015 Oct 23.
3
Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.重编程因子的残留表达会影响诱导多能干细胞的转录程序和表观遗传特征。
PLoS One. 2012;7(12):e51711. doi: 10.1371/journal.pone.0051711. Epub 2012 Dec 14.
4
Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy.表观遗传学在细胞重编程中的作用;从 iPSCs 到疾病建模和细胞治疗。
J Cell Biochem. 2022 Feb;123(2):147-154. doi: 10.1002/jcb.30164. Epub 2021 Oct 19.
5
Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.诱导多能干细胞重编程:表观遗传学及其在再生医学中的应用。
Rev Assoc Med Bras (1992). 2017 Feb;63(2):180-189. doi: 10.1590/1806-9282.63.02.180.
6
Epigenetic memory in induced pluripotent stem cells.诱导多能干细胞中的表观遗传记忆。
Nature. 2010 Sep 16;467(7313):285-90. doi: 10.1038/nature09342.
7
Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.细胞重编程诱导多能性的转录和表观遗传机制。
Epigenomics. 2016 Aug;8(8):1131-49. doi: 10.2217/epi-2016-0032. Epub 2016 Jul 15.
8
The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.miR-302介导的多能干细胞(iPSC)诱导:多种协同重编程机制
Methods Mol Biol. 2018;1733:283-304. doi: 10.1007/978-1-4939-7601-0_23.
9
Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.细胞起源类型会影响诱导多能干细胞的产生以及向血液内皮谱系细胞的分化。
Cell Tissue Res. 2016 Jul;365(1):101-12. doi: 10.1007/s00441-016-2369-y. Epub 2016 Feb 19.
10
Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine.人诱导多能干细胞:从细胞起源、基因组稳定性和表观遗传记忆到转化医学。
Stem Cells. 2022 Jun 22;40(6):546-555. doi: 10.1093/stmcls/sxac020.

引用本文的文献

1
A new human model of cytotypic and testosterone-producing organoids derived from testicular tissue of transgender women.一种源自跨性别女性睾丸组织的细胞类型和产生睾酮的类器官的新型人类模型。
Hum Reprod Open. 2025 Aug 20;2025(3):hoaf043. doi: 10.1093/hropen/hoaf043. eCollection 2025.
2
MicroRNA profiles of four induced pluripotent stem cell lines derived from distinct tissues.源自不同组织的四种诱导多能干细胞系的微小RNA谱。
BMC Res Notes. 2025 Aug 17;18(1):356. doi: 10.1186/s13104-025-07437-3.
3
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery.

本文引用的文献

1
Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage.利用 Sendai 病毒载体进行直接重编程修复了慢性阶段的梗死心脏。
Biochem Biophys Res Commun. 2021 Jun 30;560:87-92. doi: 10.1016/j.bbrc.2021.04.121. Epub 2021 May 10.
2
Multivariate meta-analysis reveals global transcriptomic signatures underlying distinct human naive-like pluripotent states.多变量荟萃分析揭示了不同人类原始样多能状态的全局转录组特征。
PLoS One. 2021 May 13;16(5):e0251461. doi: 10.1371/journal.pone.0251461. eCollection 2021.
3
Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues.
细胞与组织重编程:开启药物研发的新时代。
Pharmacol Rev. 2025 Jun 26;77(5):100077. doi: 10.1016/j.pharmr.2025.100077.
4
Analysis of astrocyte progenitors derived from human induced pluripotent stem cells and following transplantation into the intact spinal cord.对源自人诱导多能干细胞并移植到完整脊髓后的星形胶质细胞祖细胞的分析。
bioRxiv. 2025 Jun 28:2025.06.27.661961. doi: 10.1101/2025.06.27.661961.
5
Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders.关于使用人类诱导多能干细胞进行神经精神疾病神经药理学研究的建议、指南和最佳实践。
Neurosci Appl. 2023 Mar 20;2:101125. doi: 10.1016/j.nsa.2023.101125. eCollection 2023.
6
Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine.用于体外疾病建模和再生医学的诱导多能干细胞(iPSC)和间充质干细胞(MSC)
Int J Mol Sci. 2025 Jun 11;26(12):5617. doi: 10.3390/ijms26125617.
7
Induced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy.诱导多能干细胞在心肌病中的应用:推动疾病建模、治疗开发和再生治疗
Int J Mol Sci. 2025 May 22;26(11):4984. doi: 10.3390/ijms26114984.
8
How leaky is the gut in Parkinson's disease?帕金森病患者的肠道屏障有多渗漏?
EBioMedicine. 2025 Jun 3;117:105796. doi: 10.1016/j.ebiom.2025.105796.
9
Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy.重新审视X连锁肾上腺脑白质营养不良的发病机制。
Genes (Basel). 2025 May 17;16(5):590. doi: 10.3390/genes16050590.
10
A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications.诱导多能干细胞(iPSC)生成与应用的综合分析。
Front Cell Dev Biol. 2025 May 8;13:1593207. doi: 10.3389/fcell.2025.1593207. eCollection 2025.
重编程:焕发衰老细胞和组织活力的新兴策略。
Int J Mol Sci. 2021 Apr 13;22(8):3990. doi: 10.3390/ijms22083990.
4
Induced Pluripotency: A Powerful Tool for In Vitro Modeling.诱导多能性:体外建模的强大工具。
Int J Mol Sci. 2020 Nov 24;21(23):8910. doi: 10.3390/ijms21238910.
5
Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease.诱导多能干细胞来源于发育中的纹状体,可作为亨廷顿病细胞替代治疗的潜在供体来源。
Cytotherapy. 2021 Feb;23(2):111-118. doi: 10.1016/j.jcyt.2020.06.001. Epub 2020 Nov 25.
6
Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.基于人多能干细胞的神经退行性疾病治疗:现状与挑战。
Cells. 2020 Nov 20;9(11):2517. doi: 10.3390/cells9112517.
7
Evaluating Reprogramming Efficiency and Pluripotency of the Established Human iPSCS by Pluripotency Markers.通过多能性标志物评估已建立的人诱导多能干细胞的重编程效率和多能性。
Methods Mol Biol. 2021;2239:235-249. doi: 10.1007/978-1-0716-1084-8_15.
8
Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons.诱导多能干细胞的起源影响其向多巴胺能神经元的分化。
Int J Mol Sci. 2020 Aug 9;21(16):5705. doi: 10.3390/ijms21165705.
9
Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers.iPSC 衍生的靶向宫颈癌的复壮 T 细胞的可持续肿瘤抑制作用。
Mol Ther. 2020 Nov 4;28(11):2394-2405. doi: 10.1016/j.ymthe.2020.07.004. Epub 2020 Jul 9.
10
Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.人诱导多能干细胞在 cGMP 条件下的培养方法。
Curr Protoc Stem Cell Biol. 2020 Sep;54(1):e117. doi: 10.1002/cpsc.117.